-
Worth Watching Stocks: CymaBay Therapeutics Inc. (NASDAQ:CBAY), Banco Santander, S.A. (NYSE:SAN), Urban Outfitters Inc. (NASDAQ:URBN), Jones Energy (NYSE:JONE), First Interstate Bancsystem (NASDAQ:FIBK)
On Monday shares of CymaBay Therapeutics Inc. (NASDAQ:CBAY) closed at $3.34. May 15, CymaBay Therapeutics Inc. (NASDAQ:CBAY) announced that Harold Van Wart, Ph.D., President and Chief Executive Officer, will present a corporate update at the 2015 UBS Global Healthcare Conference on Wednesday, May 20, at 9:30 a.m. ET at the Sheraton New York Times Square…
-
Investors Are Watching: Global Cash Access Holdings (NYSE:GCA), CymaBay Therapeutics Inc. (NASDAQ:CBAY), Crawford (NYSE:CRD-B), China Information Technology (NASDAQ:CNIT), Healthways (NASDAQ:HWAY)
On Friday shares of Global Cash Access Holdings, Inc. (NYSE:GCA) closed at $8.01. Company’s sales growth for last 5 years was -2.30% and EPS growth for next 5 years is recorded as 20.00%. Zacks lowered shares of Global Cash Access Holdings (NYSE:GCA) from a buy rating to a hold rating in a research report released…
-
Traders Are Watching: CymaBay Therapeutics Inc. (NASDAQ:CBAY), Johnson & Johnson (NYSE:JNJ), American Express (NYSE:AXP), Rose Rock Midstream (NYSE:RRMS), Extra Space Storage (NYSE:EXR)
On Wednesday shares of CymaBay Therapeutics Inc. (NASDAQ:CBAY) closed at $2.87. On 8 May, CymaBay Therapeutics, Inc. (NASDAQ:CBAY) reported Q1 results. The company said, Net loss for the three months ended March 31, 2015 was $2.3 million compared to $10.1 million for three months ended March 31, 2014. The difference in net loss between these…
-
Trader’s Watch List: Pacific Drilling S.A. (NYSE:PACD), CymaBay Therapeutics Inc. (NASDAQ:CBAY), Zix Corporation (NASDAQ:ZIXI), American International Group (NYSE:AIG), ConocoPhillips (NYSE:COP)
On Thursday shares of Pacific Drilling S.A. (NYSE:PACD) closed at $4.67. Company’s EPS growth for next 5 years is recorded as 21.81%. On Apr 28, Pacific Drilling S.A. (NYSE:PACD) will release its first-quarter 2015 financial results on Monday, May 4, 2015, after the close of trading on the New York Stock Exchange. A conference call…
-
Market Movers: CymaBay Therapeutics Inc. (NASDAQ:CBAY), Sorrento Therapeutics (NASDAQ:SRNE), Customers Bancorp (NYSE:CUBI), Trustmark Corporation (NASDAQ:TRMK), Tuniu Corporation (NASDAQ:TOUR)
On Tuesday shares of CymaBay Therapeutics Inc. (NASDAQ:CBAY) closed at $4.50. On April 23, US-based biopharmaceutical firm CymaBay Therapeutics Inc. (NASDAQ:CBAY) has received orphan drug designation from the US Food and Drug Administration (FDA) for MBX-8025 to treat patients with hyperlipoproteinemia types I or V (Fredrickson classification). Sorrento Therapeutics, Inc. (NASDAQ:SRNE) in last trading activity…
-
Active Stocks to Watch: Yanzhou Coal Mining (NYSE:YZC), CymaBay Therapeutics Inc. (NASDAQ:CBAY), Capital Southwest (NASDAQ:CSWC), Inter Parfums (NASDAQ:IPAR), Walgreens Boots Alliance (NASDAQ:WBA)
On Wednesday shares of Yanzhou Coal Mining Co. Ltd. (NYSE:YZC) closed at $11.86. Company’s sales growth for last 5 years was 17.40% and EPS growth for next 5 years is recorded as 5.00%. On March 30, Yanzhou Coal Mining Company Limited (NYSE:YZC) announced its annual results for the year ended 31 December 2014 (the “Year”).…
-
Trader’s Watch List: CymaBay Therapeutics Inc. (NASDAQ:CBAY), Cancer Genetics (NASDAQ:CGIX), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Vince Holding (NYSE:VNCE), BlackBerry (NASDAQ:BBRY)
On Thursday shares of CymaBay Therapeutics Inc. (NASDAQ:CBAY) closed at $6.99. On 25 March 2015, CymaBay Therapeutics Inc. (NASDAQ:CBAY) announced the U.S. FDA has granted the company orphan drug designation for MBX-8025 as a treatment for homozygous familial hypercholesterolemia. MBX-8025 is a potent and selective peroxisome proliferator-activated receptor delta agonist being evaluated in high unmet…
-
News Buzz: Chevron Corporation (NYSE:CVX), Global Payments Inc. (NYSE:GPN), CymaBay Therapeutics Inc. (NASDAQ:CBAY), Micron Technology (NASDAQ:MU), CDI Corp. (NYSE:CDI)
Chevron Corporation (NYSE:CVX) in last trading activity moved down -1.62% to close at $104.20. Company weekly performance is 1.00% while its quarterly performance stands at -6.82%. Chevron Corporation (NYSE:CVX) is -20.73% away from its 52 week high. Chevron Corporation (NYSE:CVX) has signed a production sharing contract (PSC) with Myanmar Oil & Gas Enterprise (MOGE) to…
-
Fast Moving Stocks: CymaBay Therapeutics Inc. (NASDAQ:CBAY), Pfizer Inc. (NYSE:PFE), Cabot Microelectronics Corporation (NASDAQ:CCMP), Cablevision Systems Corporation (NYSE:CVC), BlackBerry Ltd (NASDAQ:BBRY)
On Thursday shares of CymaBay Therapeutics Inc. (NASDAQ:CBAY) closed at $9.01. CymaBay Therapeutics Inc. (NASDAQ:CBAY) on Wednesday reported a fourth-quarter loss of $12.7 million, after reporting a profit in the same period a year earlier. On a per-share basis, the Newark, California-based company said it had a loss of 87 cents. For the year, the…
-
Hot Watch List: CymaBay Therapeutics Inc. (NASDAQ:CBAY), Oncolytics Biotech Inc. (NASDAQ:ONCY), RingCentral (NYSE:RNG), Peoples Bancorp of North Carolina (NASDAQ:PEBK), Park Electrochemical (NYSE:PKE)
On March 11CymaBay Therapeutics, Inc. (NASDAQ:CBAY), announced that it will host a conference call and live audio webcast on Wednesday, March 18 at 4:15 p.m. Eastern Time (1:15 p.m. Pacific Time) to discuss the Company’s financial results for the quarter and year ended December 31, 2014 and to provide a general business update. On Monday…